Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD1433 and Conjunctive Melanoma (CM)

<< Previous

Bullboard Posts

Next >>

Comment by patience69on Sep 22, 2021 10:41am

474 Views

Post# 33898039

RE:RE:RE:RE:RE:RE:RE:RE:TLD1433 and Conjunctive Melanoma (CM)

I sure hope that you are right skys. It would be really nice to see them get a start on at least another couple of indications. We would get closer to winning with the disease and the value of our company would grow, I think we would need a share price of a couple of dollars to get all of the warrants exercised so lets hope that is soon. Maybe another round of good results in maybe a dozen patients & BTD could do that???

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale